Pharmacotherapy in the Treatment of Male Sexual Dysfunction

Journal of Sex Research, August, 2000 by David L. Rowland, Arthur L. Burnett

Labasky, R. C. (1998). Transurethral alprostadil for the treatment of erectile dysfunction: Two-year safety update [Abstract]. Journal of Urology, 159, 237.

Lal, S., Laryea, E., Thavundayil, J. X., Nair, N. P., Nagrete, J., Ackman, D., Blundell, P., & Gardiner, R. J. (1987). Apomorphine-induced penile tumescence in impotent patients-preliminary findings. Progress in Neuropsychopharmacological & Biological Psychiatry, 11, 235-342.

Lamberg, L. (1998). New drug for erectile dysfunction boon for many, "viagravation" for some [News]. Journal of the American Medical Association, 280, 867-869.

Lance, R., Albo, M., Costabile, R. A., & Steers, W. D. (1995). Oral trazodone as empirical therapy for erectile dysfunction: a retrospective review. Urology, 46, 117-120.

Laumann, E., Gagnon, J., Michael, R., & Michaels, S. (1994). The social organization of sexuality: Sexual practices in the United States. Chicago: University of Chicago Press.

Lee, H. S., Song, D. H., Kim, C. H., & Choi, H. K. (1996). An open clinical trial of fluoxetine in the treatment of premature ejaculation. Journal of Clinical Psychopharmacology, 16, 379-382.

Levine, S. (1992). Helping men to control ejaculation. In S. Levine (Ed.), Sexual life: A clinician's' guide (pp. 90-106). New York: Plenum.

Lewis, R. W. (1998). Combined use of transurethral alprostadil and an adjustable penile constriction band in men with erectile dysfunction: results from a multicenter trial [Abstract]. Journal of Urology, 159, 237.

Linet, O. I., & Neff, L. L. (1994). Intracavernous prostaglandin E1 in erectile dysfunction. Clinical Investigations, 72, 139-149.

Liner, O. I., & Ogrinc, F. G. (1996). Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. New England Journal of Medicine, 334, 873-877.

Lipschultz, L. I. & Kim, E. D. (1999). Treatment of erectile dysfunction in men with diabetes [Commentary]. Journal of the American Medical Association, 281,485-486.

Ludovico, G. M., Corvasce, A., Pagliarulo, G., Cirillo-Marucco, E., Marano, A., & Pagliarulo, A.(1996). Paroxetine in the treatment of premature ejaculation. British Journal of Urology, 77, 881-882.

Lue, T. F. (1992). Physiology of erection and pathophysiology of impotence. In P. C. Walsh, A. B. Retik, T. A. Stamey, & E. D. Vaughan, Jr. (Eds.), Campbell's urology (pp. 709-728). Philadelphia: W.B. Saunders Company.

Marson, L., & McKenna, K. E. (1992). A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes. Experimental Brain Research, 88, 313-320.

Masters, W., & Johnson, V. (1970). Human sexual inadequacy. Boston: Little, Brown.

McMahon, C. G. (1996). A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction. International Journal of Impotence Research, 8, 233-236.

McMahon, C. G. (1998a). Treatment of premature ejaculation with sertraline hydrochloride: A single-blind placebo controlled crossover study. Journal of Urology, 159, 1935-1938.